Silk Road Medical, Inc
SILK
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -56.54M | -53.42M | -55.74M | -55.35M | -52.88M |
| Total Depreciation and Amortization | 3.73M | 3.74M | 3.79M | 3.80M | 3.69M |
| Total Amortization of Deferred Charges | 235.00K | 234.00K | 232.00K | 231.00K | 241.00K |
| Total Other Non-Cash Items | 37.12M | 35.55M | 33.62M | 31.50M | 29.36M |
| Change in Net Operating Assets | -18.50M | -21.29M | -13.91M | -6.47M | -4.62M |
| Cash from Operations | -33.96M | -35.19M | -32.01M | -26.29M | -24.21M |
| Capital Expenditure | -2.13M | -1.61M | -1.51M | -2.62M | -2.68M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.07M | 6.07M | -5.67M | -107.93M | -148.22M |
| Cash from Investing | 13.94M | 4.46M | -7.18M | -110.55M | -150.90M |
| Total Debt Issued | -- | -- | -- | -1.09M | -1.09M |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 14.25M | 2.78M | 3.89M | 114.55M | 115.76M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 1.10M | 970.00K |
| Cash from Financing | 14.25M | 2.78M | 3.89M | 114.56M | 115.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.76M | -27.95M | -35.30M | -22.27M | -59.47M |
